Background: Programmed death 1 (PD-1) and the ligand of PD-1 (PD-L1) are central targets for immune-checkpoint therapy (ICT) blocking immune evasion-related pathways elicited by tumor cells. A number ...

Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, China Shenzhen Research Institute, City University of Hong Kong, Shenzhen, China Tung Research Centre, City University of ...